Differential expression of glomerular extracellular matrix and growth factor mRNA in rapid and slowly progressive glomerulosclerosis: Studies in mice transgenic for native or mutated growth hormone

Laboratory Investigation

Volumn 76, Issue 4, 1997, Pages 467-476

  Yang, Chih Wei ^a,c   Striker, Gary E ^a   Chen, Wen Y ^b   Kopchick, John J ^b   Striker, Liliane J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b OHIO UNIVERSITY   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GROWTH HORMONE; LAMININ BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; GENE MUTATION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RNA ANALYSIS;

AGING; ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELL COUNT; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GROWTH HORMONE; GROWTH SUBSTANCES; KIDNEY GLOMERULUS; MICE; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 0030938601     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ahlmen J (1975). Incidence of chronic renal insufficiency: A study of the incidence and pattern of renal insufficiency in adults during 1966-1971 in Gothenburg. Acta Med Scand 582(Suppl):1-50.
2. Border WA, Brees D, and Noble NA (1994). Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 107:140-145.
3. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, and Fish AJ (1989). Basement membrane collagen in the kidney: Regional localization of novel chains related to collagen IV. Kidney Int 35:1195-1202.
4. Cameron JS (1992). The long term outcome of glomerular diseases. In: Schrier RW and Gottschalk CW, editors. Diseases of the kidney. Boston: Little, Brown and Co., 1895-2015.
5. Carome MA, Striker LJ, Peten EP, Elliot SJ, Yang CW, Stetler-Stevenson WG, Reponen P, Tryggvason K, and Striker GE (1994). Assessment of 72 kDa gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. J Am Soc Nephrol 5:1391-1400.
6. Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, Striker GE, and Kopchick JJ (1995). Effect of STZ treatment on GH and GH- antagonist TGFB β1 transgenic mice. Endocrinology 136:660-668.
7. Chen WY, Wight DC, Chen NY, Coleman TA, Wagner TE, and Kopchick JJ (1991). Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice. J Biol Chem 266:2252-2258.
8. Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, and Striker GE (1990). Glomerular lesions in mice transgenic for growth hormone and insulin like growth factor-I: Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 137:541-552.
9. Doi T, Striker LJ, Kimata K, Peten EP, Yamada Y, and Striker GE (1991). Glomerulosclerosis in mice transgenic for growth hormone: Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287-1290.
10. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, and Striker GE (1988). Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1. Am J Pathol 131:398-403.
11. Ebihara I, Suzuki S, Nakamura T, Fukui M, Yaguchi Y, Tomino Y, and Koide H (1993). Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis. J Am Soc Nephrol 3:1387-1397.
12. El Nahas AM, Bassett AH, Cope GH, and le Carpentier JE (1991). Role of growth hormone in the development of experimental renal scarring. Kidney Int 40:29-34.
13. Engel J (1989). EGF-like domain in extracellular matrix proteins: Localized signals for growth and differentiation? FEBS Lett 251:1-7.
14. Esposito C, Striker LJ, Patel A, Peten E, Liu ZH, and Striker GE (1996). Molecular analysis of glomerular diseases in renal biopsies: Initial results of a collaborative international study. Proc Am Assoc Physicians 108:209-217.
15. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, and Johnson RJ (1992a). Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497.
16. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, and Johnson RJ (1992b). Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309.
17. Floege J, Johnson RJ, and Couser WG (1992c). Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. J Clin Invest 70:857-864.
18. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, and Koide H (1992). ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527.
19. Hudson BG, Reeders ST, and Tryggvason K (1993). Type IV collagen: Structure, gene organization, and role in human diseases: Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268:26033-26036.
20. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, and Imai E (1993). Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601.
21. Johnson RJ, Floege J, Couser WG, and Alpers CE (1993). Role of platelet-derived growth factor in glomerular disease (editorial). J Am Soc Nephrol 4:119-128.
22. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, and Striker G (1994). The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884.
23. Liu ZH, Striker LJ, Phillips C, Chen NY, Chen WY, Kopchick JJ, and Striker GE (1995). Growth hormone expression is required for the development of glomerulosclerosis in mice. Kidney Int Suppl 48:S37-S38.
24. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR, and Glassock RJ (1989). Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114:66-74.
25. Mackie EJ, Halfter W, and Liverani D (1988). Induction of tenascin in healing wounds. J Cell Biol 107:2757-2767.
26. Mori H, Yamashita H, Nakanishi C, Koizumi K, Makino, S, Kishimoto Y, and Hayashi Y (1986). Proteinuria induced by transplantable rat pituitary tumor MtT sA5: Model for homologous protein-overload proteinuria. Lab Invest 54: 636-644.
27. Nakamura T, Ebihara I, Fukui M, Osada S, Nagaoka I, Horikoshi S, Tomino Y, and Koide H (1993a). Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis. Clin Immunol Immunopathol 66:33-42.
28. Nakamura T, Fukui M. Ebihara I, Osada S, Nagoaka I, Tomino Y, and Koide H (1993b). mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456.
29. Nakamura T, Miller D, Ruoslahti E, and Border WA (1992). Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta-1. Kidney Int 41:1213-1221.
30. Pesce CM, Striker LJ, Peten E, Elliot SJ, and Striker GE (1991). Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605.
31. Peten EP, Garcia-Perez A, Terada Y, Woodrow D, Martin BM, Striker GE, and Striker LJ (1992a). Age-related changes in alpha 1- and alpha 2-chain type iv collagen mRNAs in adult mouse glomeruli: Competitive PCR. Am J Physiol 263:F951-F957.
32. Peten EP, Striker LJ, Carome MA, Elliott SJ, Yang CW, and Striker GE (1992b). The contributions of increased collagen synthesis to human glomerulosclerosis: A quantitative analysis of alpha-2 IV collagen mRNA expression by competitive polymerase chain reaction. J Exp Med 176:1571-1576.
33. Peten EP, Striker LJ, Garcia-Perez A, and Striker GE (1993). Studies by competitive PCR of glomerulosclerosis in growth hormone transgenic mice. Kidney Int Suppl 39:S55-S58.
34. Prieto AL, Andersson-Fisone C, and Crossin KL (1992). Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotaxin. J Cell Biol 119:663-678.
35. Prieto AI, Edelman GM, and Crossin KL (1993). Multiple integrins mediate cell attachment to cytotaxin/tenascin. Proc Natl Acad Sci USA 90:10154-10158.
36. Roberts AB, McCune BK, and Sporn MB (1992). TGF-beta: Regulation of extracellular matrix. Kidney Int 41:557-559.
37. Ruegg CR, Chiquet-Ehrismann R, and Alkan SS (1989). Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc Natl Acad Sci USA 86:7437-7441.
38. Sharma K and Ziyadeh FN (1993). The transforming growth factor-beta system and the kidney. Semin Nephrol 13:116-128.
39. Sterzel RB, Schulze-Lohoff E, and Marx M (1993). Cytokines and mesangial cells. Kidney Int Suppl 39:326-831.
40. Stewart TA, Clift S, Pitts-Meek S, Martin L, Terrell TG, Liggitt D, and Oakley H (1992). An evaluation of the functions of the 22-kilodalton(kDa), the 20-kDa, and the n-terminal polypeptide forms of human growth hormone using transgenic mice. Endocrinology 130:404-414.
41. Striker GE, Peten EP, Carome MA, Elliot SJ, Schmidt K, Yang CW, Elliot SJ, and Striker LJ (1993). The kidney disease of diabetes mellitus (KDDM): A cell and molecular biology approach. Diabetes Metab Rev 9:37-57.
42. Suzuki S, Ebihara I, Tomino Y, and Koide H (1993). Transcriptional activation of matrix genes by transforming growth factor-beta-1 in mesangial cells. Exp Nephrol 1:229-237.
43. Truong LD, Pindur J, Barrios R, D'Agati V, Lechago J, Suki W, and Majesky M (1994). Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions. Kidney Int 45:201-210.
44. Trachtman H, Futterweit S, Schwob N, Maesaka J, and Valderrama E (1993). Recombinant human growth hormone exacerbates chronic puromycin aminonucleoside nephropathy in rats. Kidney Int 44:1281-1288.
45. Walser M (1990). Progression of chronic renal failure in man. Kidney Int 37:1195-1210.
46. Wyndhan JR, Everitt AV, Eyland A, Major J (1987). Inhibitory effect of hypophysectomy and food restriction on glomerular basement membrane thickening, proteinuria and renal enlargement in aging male Wistar rats. Arch Gerontol Geriatr 6:323-337.
47. Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick JJ, and Striker GE (1993). Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone: Studies in transgenic mice. Lab Invest 68:62-70.
48. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, and Striker LJ (1994). Advanced glycosylation endproducts upregulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440.
49. Yoshida H, Mitarai T, Kitamira M, Szuki T, Ishikawa H, Fogo A, and Sakai O (1994). The effect of selective growth hormone defect in the progression of glomerulosclerosis. Am J Kidney Dis 23:302-312.